Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yutian Capsule is a Traditional Chinese Medicine (TCM) formulation primarily indicated for the treatment of psoriasis, specifically targeting the "blood-heat" and "blood-dryness" clinical patterns. Developed and manufactured by Shaanxi Yutian Pharmaceutical, the capsule contains a complex blend of herbal extracts including *Rehmannia glutinosa*, *Angelica sinensis*, and *Salvia miltiorrhiza*. Its therapeutic mechanism is based on TCM principles of cooling the blood, dispelling wind, and moisturizing dryness to alleviate symptoms such as erythema, scaling, and pruritus. In clinical practice within China, it is utilized as an oral systemic therapy for chronic plaque psoriasis, where it is believed to modulate the immune response and reduce inflammatory cytokine levels associated with psoriatic skin lesions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yutian Capsule.